ASX Today, page-34394

First 34394 Last

Share
Profile

Follow
yacheng

7,993 Posts.

649

11/11/23

11:30

Post #: 70845348
Share

Originally posted by dynofish: ↑

Hi yacheng...
I think the issue is multi fold...I tend to agree that the price is being walked down, but why? Short sellers profit from it, yes. When do short sellers cover? When the signals from the market are positive, like rising indicators of EV sales, spot chemical prices bottoming (only small quantities are sold at spot), and global major economies showing growth or stimulus. It seems to me that several of these indicators are showing favourable signs. So as it turns, there is likely to be a reasonably swift rise, and we know there is a major catalyst approaching for LTR...project commissioning and production.

LTR is not yet a producer so there is no tangible impact on value for our company, only on sentiment in the industry. Anyone who examines institutional substantial shareholder notices can see that there is a patient and elongated process of increasing (as well as reducing at times), their holdings. They also switch between stocks to create volatility while managing overall industry exposures where they want. My view is that once we turn on our plant, the sentiment and valuation for the company will respond. It will be too late then to acquire a long term holding at low prices.

I do not believe I am naive in buying gradually while tracking trading. My last buy of 20,000 shares was at $1.555 about a week ago. A family member bought at $1.565 and has an order in the queue at $1.495.

I have an investor view rather than a trader view. I am happy that around current prices there is good value available for a long term investor. Clearly, the institutions who recently paid $1.80 per share thought so too. There is one more factor, and that is the very real possibility of a new takeover offer for our shares! It is always darkest before the dawn as they say, and one day earlier this year we woke up and found our share price up $1.00 in a single day. What preceded that event was months of similar trading activity to what we see now. Also, identical behaviour happened before WES took over Kidman Resources.

I am happy to take my own views of valuation and cues from large investors as well as the company's unique position as a fully funded imminent producer of a strategically valuable chemical product of the future.

regards
DF

Expand

All about trend!!... trending down!.. wait till it turns!...
Maybe buy the Book ... Share trading for Dummies...
May help...imho...lol

LTR Price at posting: $1.50 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 10,324 more messages in this thread...

First 34394 Last

Add LTR (ASX) to my watchlist

(20min delay)
Last 75.0¢		Change -0.020(2.60%)		Mkt cap ! $1.867B

Open	High	Low	Value	Volume
77.0¢	77.0¢	74.0¢	$2.166M	2.867M

Buyers (Bids)

No.	Vol.	Price($)
5	33201	75.0¢

Sellers (Offers)

Price($)	Vol.	No.
75.5¢	89821	16

View Market Depth

No.	Vol.	Price($)
11	217217	0.745
35	432472	0.740
19	516558	0.735
22	639345	0.730
15	1143777	0.725

Price($)	Vol.	No.
0.750	123251	20
0.755	217459	15
0.760	102551	7
0.765	147329	5
0.770	109890	5

Last trade - 10.35am 04/10/2024 (20 minute delay)

LTR (ASX) Chart

ASX Today, page-34394

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

ASX Today, page-34394

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News